molindone has been researched along with olanzapine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glazer, WM | 1 |
Ambler, D; Anderson, R; Findling, RL; Frazier, JA; Hamer, RM; Hlastala, SA; Hunt-Harrison, T; Lieberman, JA; Maloney, AE; McCLELLAN, J; Ritz, L; Sikich, L; Vitiello, B; Williams, E | 1 |
Ambler, D; Anderson, R; De Jong, S; Delporto-Bedoya, D; Findling, RL; Frazier, JA; Hamer, RM; Hlastala, S; Lieberman, JA; Maloney, AE; McClellan, J; McNamara, NK; Michael, E; Noyes, N; Pierson, L; Puglia, M; Ritz, L; Sikich, L; Slifka, K; Vitiello, B | 1 |
Findling, RL; Frazier, JA; Hamer, RM; Hlastala, S; Johnson, JL; Kaufman, EM; Lieberman, JA; Lingler, J; Maloney, AE; McClellan, J; McNamara, NK; Noyes, N; Pierson, L; Puglia, M; Ritz, L; Sikich, L; Vitiello, B | 1 |
Bachman, P; Bearden, CE; Jalbrzikowski, M | 1 |
Breiger, D; Findling, RL; Frazier, JA; Giuliano, AJ; Hamer, RM; Hooper, SR; Johnson, JL; Lieberman, JA; McClellan, J; Sikich, L; Vitiello, B; Yakutis, L; Youngstrom, EA | 1 |
Datta, SS; Furtado, VA; Kumar, A; Russell, PS; Wright, SD | 1 |
Alexander-Bloch, A; Appel, S; Bloch, MH; Eli, M; Gur, RE; Maayan, L; Taylor, JH | 1 |
Arango, C; Leucht, S; Lopez-Morinigo, JD | 1 |
3 review(s) available for molindone and olanzapine
Article | Year |
---|---|
Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Humans; Incidence; Molindone; Olanzapine; Pirenzepine; Prospective Studies; Risk Factors; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Survival Analysis | 2000 |
Atypical antipsychotics for psychosis in adolescents.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Molindone; Olanzapine; Piperazines; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia | 2013 |
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Haloperidol; Humans; Lurasidone Hydrochloride; Molindone; Olanzapine; Paliperidone Palmitate; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Systematic Reviews as Topic | 2022 |
6 trial(s) available for molindone and olanzapine
Article | Year |
---|---|
Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Humans; Incidence; Molindone; Olanzapine; Pirenzepine; Prospective Studies; Risk Factors; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Survival Analysis | 2000 |
Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Benzodiazepines; Child; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Molindone; Olanzapine; Risperidone; Schizophrenia; Time Factors | 2007 |
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Double-Blind Method; Female; Humans; Male; Molindone; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 2008 |
Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study.
Topics: Adolescent; Akathisia, Drug-Induced; Benzodiazepines; Child; Double-Blind Method; Female; Humans; Long-Term Care; Male; Molindone; Olanzapine; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Psychotropic Drugs; Risk Factors; Risperidone; Schizophrenia; Schizophrenic Psychology; Weight Gain; Young Adult | 2010 |
Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Child; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Molindone; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 2012 |
Time to Clinical Response in the Treatment of Early Onset Schizophrenia Spectrum Disorders Study.
Topics: Adolescent; Age of Onset; Antipsychotic Agents; Child; Female; Humans; Male; Molindone; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; United States | 2021 |
3 other study(ies) available for molindone and olanzapine
Article | Year |
---|---|
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain | 2003 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
The voices go, but the song remains the same: how can we rescue cognition in early-onset schizophrenia?
Topics: Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Female; Humans; Male; Molindone; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 2012 |